LT - Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
EN - Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
G01N 33/68 |
|
|
|
G01N 33/74 |
|
European patent
| (11) |
Number of the document |
2293076 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
10188289.2 |
|
Date of filing the European patent application |
2008-08-01 |
| (97) |
Date of publication of the European application |
2011-03-09 |
| (45) |
Date of publication and mention of the grant of the patent |
2012-12-19
|
| (46) |
Date of publication of the claims translation |
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
07015271 |
2007-08-03
|
EP |
|
08152651 |
2008-03-12
|
EP |
Inventors
| (72) |
Struck, Joachim, DE
Bergmann, Andreas, DE
|
Grantee
| (73) |
B.R.A.H.M.S GmbH,
Neuendorfstrasse 25, 16761 Hennigsdorf,
DE
|
Title
| (54) |
Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease |
| |
Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease |
